Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 194

Icon constructs $207m series B round

BIG-Bjarke Ingels Group, Ensemble and Citi all provided series B funding for the advanced construction technology developer, which also counts a number of real estate firms as investors.

Aug 25, 2021

Certik certifies $24m series B-plus

Yale and Columbia-linked Certik has secured $24m in additional funding, just one month after securing $37m in its series B round.

Aug 25, 2021

Forage finds series B investors

ASU-backed Forage has added Telstra Ventures and Citi Ventures to its list of shareholders through a $25m series B round.

Aug 25, 2021

Techcyte takes in $21m

Utah spinout Techcyte has received $21m in funding, three and a half years after its series A round.

Aug 25, 2021

Novasenta emerges with $20m

Exploiting research at University of Pittsburgh and UPMC, Novasenta has been established with $20m in seed financing.

Aug 25, 2021

Bungalow to house $75m in series C

The CAA Ventures-backed apartment network secured a valuation of over $600m through an ongoing series C round it announced this week.

Aug 25, 2021

Dice Molecules comes up trumps with $60m

The series C1 round pushed the Sanofi and Alexandria Real Estate Equities-backed oral therapeutics developer’s total funding to about $200m.

Aug 25, 2021

Elixiron concocts $27m series A round

Immunotherapy developer Elixiron has closed its series A1 round with capital from investors including Hong Tai Electric Industrial.

Aug 25, 2021

Dice Molecules rolls to $60m series C1

Osage University Partners is among the returning backers that have helped push Stanford-linked Dice Molecules’ total funding to around $200m.

Aug 25, 2021

Daily Deal Round Up: August 24, 2021

TXOne Nertworks has added $12.9m to its coffers, while C3 has pushed its series B round to $90m thanks to a $10m extension.

Aug 24, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here